J. Matsumoto

发表

Effect of CYP3A5*3 genetic variant on the metabolism of direct-acting antivirals in vitro: a different effect on asunaprevir versus daclatasvir and beclabuvir

H. Sakaue, Masachika Fujiyoshi, Hiroyoshi Nakamura, 2019, Journal of Human Genetics.

Minor contribution of CYP3A5 to the metabolism of hepatitis C protease inhibitor paritaprevir in vitro

H. Sakaue, Masachika Fujiyoshi, N. Ariyoshi, 2018, Xenobiotica; the fate of foreign compounds in biological systems.

Development of a simple method for detection of the HLA-A*31:01 allele.

I. Ishii, N. Ariyoshi, M. Kitada, 2013, Drug metabolism and pharmacokinetics.

A proposed simple screening method to determine relative contributions of CYP 3 A 4 and CYP 3 A 5 to drug metabolism in vitro Author names and affiliations :

H. Sato, Naoki Ikeda, Masachika Fujiyoshi, 2020 .

A proposed simple screening method to determine relative contributions of CYP3A4 and CYP3A5 to drug metabolism in vitro

Naoki Ikeda, Masachika Fujiyoshi, H. Yamada, 2019, Personalized Medicine Universe.

Functional characterization of seven single-nucleotide polymorphisms of the steroid sulfatase gene found in a Japanese population

I. Ishii, N. Ariyoshi, M. Kitada, 2013, Journal of Human Genetics.

Linezolid-Induced Thrombocytopenia Is Caused by Suppression of Platelet Production via Phosphorylation of Myosin Light Chain 2.

Y. Nishi, Masataka Tajima, J. Matsumoto, 2016, Biological & pharmaceutical bulletin.

Adverse Events of Axitinib plus Pembrolizumab Versus Lenvatinib plus Pembrolizumab: A Pharmacovigilance Study in Food and Drug Administration Adverse Event Reporting System.

M. Araki, Y. Nasu, M. Kajizono, 2022, European urology focus.

Blood concentrations of tacrolimus upon conversion from rabeprazole to vonoprazan in renal transplant recipients: Correlation with cytochrome P450 gene polymorphisms.

Masami Watanabe, H. Sugiyama, T. Sadahira, 2021, Drug metabolism and pharmacokinetics.

Organic anion transporting polypeptide 2B1 expression correlates with uptake of estrone-3-sulfate and cell proliferation in estrogen receptor-positive breast cancer cells.

T. Nakanishi, Y. Nakatani, I. Tamai, 2015, Drug metabolism and pharmacokinetics.

Significance of UGT1A6, UGT1A9, and UGT2B7 genetic variants and their mRNA expression in the clinical outcome of renal cell carcinoma

M. Araki, Y. Nasu, K. Wada, 2022, Molecular and Cellular Biochemistry.

Effect of CYP3A5*3 genetic variant on the metabolism of direct-acting antivirals in vitro: a different effect on asunaprevir versus daclatasvir and beclabuvir

H. Sakaue, Masachika Fujiyoshi, Hiroyoshi Nakamura, 2019, Journal of Human Genetics.

Relevance of CYP3A5 Expression on the Clinical Outcome of Patients With Renal Cell Carcinoma

Y. Nasu, K. Wada, Masachika Fujiyoshi, 2021, AntiCancer Research.

[Awareness about the Establishment of Clinical Evidence among Community Pharmacists: A Large-scale Survey among Members of the Okayama Pharmaceutical Association].

J. Matsumoto, Madoka Itano, Naohiro Iwata, 2023, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

Evaluation of cardiovascular toxicity of the atezolizumab and bevacizumab combination

K. Ishizawa, Y. Izawa-Ishizawa, T. Niimura, 2023, Frontiers in Drug Safety and Regulation.